Clinical Trials in Pittsburgh

Showing 10381-10400 of 21,047 trials

Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers

NCT03515551

IMCnyeso is a bispecific fusion protein designed for the treatment of cancers that express NY-ESO-1 and/or LAGE-1A. This was a first-in-human trial designed to evaluate the safety and efficacy of IMCnyeso in HLA-A\*02:01-positive adult participants whose cancer is positive for NY-ESO-1 and/or LAGE-A1.

Select Advanced Solid Tumors

Immunocore Ltd29 participantsStarted Jun 2018

Aurora, Colorado, United States • Iowa City, Iowa, United States • St Louis, Missouri, United States +9 more locations

TERMINATEDPhase 1< 1 mile

Phase 1, Dose-Escalation Study of IGN002 in NHL Subjects

NCT02519270

A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Intravenous Doses of IGN002 Administered Weekly to Subjects with Refractory Non-Hodgkin Lymphoma (NHL)

Non-Hodgkin Lymphoma

Spectrum Pharmaceuticals, Inc62 participantsStarted May 2016

Santa Monica, California, United States • Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 4< 1 mile

Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD

NCT00500071

Assess the efficacy \& tolerability of Vyvanse when children aged 6-12 years diagnosed with ADHD are dosed to optimal effect.

Attention Deficit Hyperactivity Disorder (ADHD)

Shire318 participantsStarted Jun 2007

Scottsdale, Arizona, United States • El Centro, California, United States • Rolling Hills Estates, California, United States +43 more locations

Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers

Phase 1, Dose-Escalation Study of IGN002 in NHL Subjects

Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD

Find Trials by Condition in Pittsburgh

AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH)

A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo

An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia

The Baby CHAMP Study (Children With Hemiparesis Arm and Movement Project)

Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)

A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis

Narcotic vs. Non-narcotic Pain Study Protocol

Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer

REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia

Home OCT Fluid Visualization Agreement Study

Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy

Sleep Apnea and Fetal Growth Restriction

Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care

A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis

Non Exudative AMD Imaged With SS-OCT- Extension

Non Exudative AMD Imaged With SS-OCT

Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants